ROSEMARY BERGERON-JOHNSON: Open Payments
NPI 1043255318 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 8 payments from 4 companies in 2025. Trend: 2023 $94 · 2024 $166 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $108 |
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
Products named: ETERNA, UZEDY, COBENFY, INGREZZA, AUSTEDO XR.
Industry payments across WA — which companies pay providers there.
